A BuiltForAI Property
Drug class profile · refreshed daily from federal data

Thiazide-like Diuretic

6 molecules in this class, $99.9M combined CY2024 Part D spend across 5.9M claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the Thiazide-like Diuretic class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class
6tracked in Part D
CY24 Part D spend
$99.9Mcombined across class
Total Rx claims
5.9M2.1M unique beneficiaries
Generic mfrs (active)
35across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard
01
Chlorthalidone
Brand: HEMICLOR · 4.4M Part D claims (CY24) · 1.5M beneficiaries · First FDA approval:
16 generic mfrs 0 plans require PA
Low NADAC$0.085
Avg plan cost$0.187
Part D spend $71.4M spread, current vs floor
Class share
71%
of class CY24 spend
View profile →
02
Metolazone
956K Part D claims (CY24) · 353K beneficiaries · First FDA approval:
10 generic mfrs 0 plans require PA
Low NADAC$0.222
Avg plan cost$0.279
Part D spend $20.8M spread, current vs floor
Class share
21%
of class CY24 spend
View profile →
03
Indapamide
552K Part D claims (CY24) · 181K beneficiaries · First FDA approval:
3 generic mfrs 0 plans require PA
Low NADAC$0.105
Avg plan cost$0.111
Part D spend $7.8M spread, current vs floor
Class share
8%
of class CY24 spend
View profile →
04
Atenolol and Chlorthalidone
Brand: TENORETIC · Part D claims (CY24) · First FDA approval:
5 generic mfrs 0 plans require PA
Low NADAC$0.265
Avg plan cost$0.303
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →
05
Atenolol and Chlorthalidone Tablet
Brand: ATENOLOL AND CHLORTHALIDONE · Part D claims (CY24) · First FDA approval:
Brand-only (no generics)
Low NADAC
Avg plan cost
Part D spend  
Class share
0%
of class CY24 spend
View profile →
06
Azilsartan Kamedoxomil and Chlorthalidone
Brand: Edarbyclor · Part D claims (CY24) · First FDA approval:
1 generic mfrs 0 plans require PA
Low NADAC$8.49
Avg plan cost$8.50
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →